Pleading for phase V clinical trials in oncology

被引：0
|
作者：
Gligorov, J. [1 ]
Debrix, I.
Boelle, P. -Y. [2 ]
Flahault, A. [1 ]
机构：
[1] Univ Paris 06, APHP Tenon, INSERM, Unite Sante Publ,U707, F-75970 Paris 20, France
[2] Univ Paris 06, APHP St Antoine, INSERM, Unite Sante Publ,U707, F-75012 Paris, France
来源：
ONCOLOGIE | 2008年 / 10卷
关键词：
D O I：
10.1007/s10269-008-0886-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S97 / S99
页数：3
相关论文
共 50 条
  • [31] Phase III trials in oncology
    Imadalou, K
    Cvitkovic, E
    BULLETIN DU CANCER, 1999, 86 (02) : 143 - 147
  • [32] Clinical outcome and survival of patients participating in oncology phase I trials
    Florescu, A.
    Chau, N. G.
    Chan, K. K.
    Wang, L.
    Chen, E. X.
    Oza, A. M.
    Siu, L. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [33] On the road to new drugs in clinical oncology: benefit of phase 2 trials
    Hochster, Howard S.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2025,
  • [34] THE ETHICAL APPROACH TO PHASE-I CLINICAL-TRIALS IN ONCOLOGY
    DURRY, G
    DION, S
    DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 1986, 12 (1-3) : 21 - 22
  • [35] Age and race distribution in patients in phase III oncology clinical trials
    Gopishetty, Swathi
    Kota, Vamsi
    Guddati, Achuta K.
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2020, 12 (09): : 5977 - 5983
  • [36] Understanding patient expectations in early-phase clinical oncology trials
    Weinfurt, K. P.
    Seils, D. M.
    Tzeng, J. P.
    Compton, K. L.
    Sulmasy, D. P.
    Astrow, A. B.
    Schulman, K. A.
    Meropol, N. J.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2007, 22 : 98 - 98
  • [37] Integrated phase II/III clinical trials in oncology: A case study
    Wang, Meihua
    Dignam, James J.
    Zhang, Qiang E.
    DeGroot, John F.
    Mehta, Minesh P.
    Hunsberger, Sally
    CLINICAL TRIALS, 2012, 9 (06) : 741 - 747
  • [38] Precision Oncology for Cancer Immunotherapies in Early-Phase Clinical Trials
    Paliard, Xavier
    Rixe, Olivier
    TARGETED ONCOLOGY, 2019, 14 (06) : 631 - 637
  • [39] Bayesian optimal interval design for phase I oncology clinical trials
    Fellman, Bryan M.
    Yuan, Ying
    STATA JOURNAL, 2015, 15 (01): : 110 - 120
  • [40] Precision Oncology for Cancer Immunotherapies in Early-Phase Clinical Trials
    Xavier Paliard
    Olivier Rixe
    Targeted Oncology, 2019, 14 : 631 - 637
12345